Study details
Enrolling now
Accelerated TMS for Depression
Neuronetics
NCT IDNCT07147218ClinicalTrials.gov data as of Apr 2026
Target enrollment
50
Study length
about 2.4 years
Ages
15+
Locations
3 sites in NC, NY, WA
About this study
This trial is testing a new way to treat depression using Accelerated Transcranial Magnetic Stimulation (TMS). The goal is to see if this treatment can help people with Major Depressive Disorder (MDD) feel better.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use TMS
Primary goalChange in MADRS score from baseline to post-treatment
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low6%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Change in MADRS score from baseline to post-treatment.
Secondary: Change in PHQ-9 from baseline to post-treatment.
Devices
therapeutic
Body systems
Psychiatry / Mental Health